• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Baseline responses of multiple sclerosis patients participating in the proms survey: impact of disease-modifying therapies and support services on patient-reported outcomes
The PROMs (Patient–Reported Outcome Measures) Survey is an ongoing, observational, prospective, cohort survey of UK patients newly diagnosed with relapsing Multiple Sclerosis (MS) receiving an injectable disease–modifying drug (DMD) (subcutaneous [sc] interferon [IFN] beta–1a or ‘other DMD’). The survey was designed to establish the impact of DMDs and associated support services on patient–reported experience measures and outcomes in MS, in response to proposed National Health Service (NHS) reforms for the reimbursement of DMDs for MS. Independent homecare companies responsible for deliv...
Source: Journal of Neurology, Neurosurgery and Psychiatry - October 9, 2013 Category: Neurosurgery Authors: Shields, S., Parkes, L. Tags: Immunology (including allergy), Multiple sclerosis, Pain (neurology) Association of British Neurologists (ABN) joint meeting with the Royal College of Physicians (RCP), London, 23-24 October 2013 Source Type: research